MYCN and embryonal neoplasm: The delineation of the mechanistic underpinnings of MYCN oncogenic activity in pediatric embryonal tumors provides a rationale to target both these cofactors simultaneously, which has important therapeutic implications for patients with MYCN-driven tumors.